<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00852930</url>
  </required_header>
  <id_info>
    <org_study_id>090118</org_study_id>
    <nct_id>NCT00852930</nct_id>
  </id_info>
  <brief_title>Low Level Laser Treatment and Breast Cancer Related Lymphedema</brief_title>
  <official_title>Low Level Laser Treatment and Breast Cancer Related Lymphedema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Manual Lymphatic Drainage (massage therapy) with compression (wearing a tight sleeve on the
      arm) is the current standard of treatment for breast cancer related lymphedema (arm
      swelling). Low-Level Laser Therapy (LLLT) was approved in 2006 by the FDA for professional
      and self/home treatment of lymphedema. LLLT is being offered as a treatment option in many
      lymphedema treatment settings, but there are few studies of the effectiveness of LLLT as a
      stand-alone lymphedema treatment or as a possible complementary lymphedema treatment modality
      to Manual Lymphatic Drainage. The objective of this proposed pilot study is to examine the
      impact of Advance Practice Nurse (ANP) administered LLLT, as both a stand-alone and
      complementary treatment, on arm volume, symptoms, and quality of life (QOL) in breast cancer
      survivors with lymphedema. Findings from this pilot study will be used to determine if LLLT
      has possible value in the treatment of lymphedema and warrants subsequent evaluation in a
      larger study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this proposed pilot study is to examine the impact of Advance Practice Nurse
      (ANP) administered LLLT, as both a stand-alone and complementary treatment, on arm volume,
      symptoms, and quality of life (QOL) in breast cancer survivors with related LE. Findings from
      this pilot randomized study will be used to determine if LLLT has possible value in the
      treatment of LE and warrants subsequent evaluation in a larger study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LDex Change-</measure>
    <time_frame>Bioimpedance at baseline and end of treatment with the average number of treaments being 9 conducted over a median of up to 4 weeks.</time_frame>
    <description>Bioimpedance measured by units of LDex. As extracellular fluid accumulates (i.e. lymphedema develops) the LDex value increases.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Whole Arm Volume Difference</measure>
    <time_frame>Baseline and on last day of treatment with average number of treatments being 9 conducted over a median of up to 4 weeks.</time_frame>
    <description>Whole arm measurement to determine volume.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms</measure>
    <time_frame>Self report on last day of treatment with average treatments being 9 conducted over a median of up to 4 weeks.</time_frame>
    <description>Yes/no response to a symptom listed on the Lymphedema Symptom Intensity and Distress Scale-Arm (LSIDS-A) self-report form.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Self-report on last day of treatment with average number of treatments being 9 conducted over a median of up to 4 weeks.</time_frame>
    <description>The Functional Assessment of Chronic Illness Therapy that measure quality of life -total score. Range of scores could be 0 to 148. Higher score represents higher quality of life.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Lymphedema</condition>
  <arm_group>
    <arm_group_label>laser alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention was therapist administered low level laser therapy using low level laser, number of sessions based upon patient response</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mld alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The intervention was therapist administered manual lymphatic drainage (mld) using standard massage techniques,number of sessions based upon patient response</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laser and mld combined</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention was therapist administered low level laser and mld using low level laser and standard massage techniques, number of sessions based upon patient response</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laser and MLD combined</intervention_name>
    <description>The intervention is therapist administered laser and mld treatment combined</description>
    <arm_group_label>laser and mld combined</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laser alone</intervention_name>
    <description>The intervention is therapist administered laser</description>
    <arm_group_label>laser alone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>manual lymphatic drainage</intervention_name>
    <description>The intervention is therapist administered manual lymphatic drainage</description>
    <arm_group_label>mld alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Breast cancer survivors will be included if they:

          1. are age 21 or older;

          2. require professional treatment for Stage I or II lymphedema as defined by the
             International Society of Lymphology;

          3. have an order for lymphedema treatment; and

          4. are willing and able to drive to the study sites.

        Exclusion Criteria:

        Individuals will not be included if they:

          1. are actively undergoing intravenous chemotherapy or radiation therapy;

          2. have a history of bilateral lymphedema that prohibits extracellular fluid comparison
             to an unaffected limb;

          3. are unable to stand upright for measurement of height and weight;

          4. have active/metastatic cancer;

          5. are pregnant,:

          6. have artificial joints in areas where electrode placement is critical, or have a
             pacemaker/internal defibrillator; or

          7. have congestive heart failure (CHF), chronic/acute renal or hepatic disease, pulmonary
             edema, thrombophlebitis, deep vein thrombosis (DVT), acute infection of any kind, and
             inflammation in the trunk or arms.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>sheila h ridner, phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt Univeristy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University School of Nursing</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2009</study_first_submitted>
  <study_first_submitted_qc>February 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2009</study_first_posted>
  <results_first_submitted>July 17, 2015</results_first_submitted>
  <results_first_submitted_qc>September 30, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 2, 2015</results_first_posted>
  <last_update_submitted>April 7, 2017</last_update_submitted>
  <last_update_submitted_qc>April 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Sheila Ridner</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>lymphedema</keyword>
  <keyword>quality of life</keyword>
  <keyword>breast cancer</keyword>
  <keyword>symptoms</keyword>
  <keyword>lymphedema in breast cancer survivors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Lymphedema</mesh_term>
    <mesh_term>Breast Cancer Lymphedema</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Laser Therapy Alone</title>
          <description>therapist administered laser treatment
laser: therapist administered laser</description>
        </group>
        <group group_id="P2">
          <title>Mld Alone</title>
          <description>therapist administered manual lymphatic drainage
manual lymphatic drainage: therapist administered massage therapy</description>
        </group>
        <group group_id="P3">
          <title>Laser and Mld Combined</title>
          <description>therapist administered laser and mld
Low Level Laser Therapy with Manual Lymphatic Drainage: therapist will give both mld and laser treatment</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>breast cancer survivors with known lymphedema</population>
      <group_list>
        <group group_id="B1">
          <title>Laser Therapy Alone</title>
          <description>therapist administered laser treatment
laser: therapist administered laser</description>
        </group>
        <group group_id="B2">
          <title>Mld Alone</title>
          <description>therapist administered manual lymphatic drainage
manual lymphatic drainage: therapist administered massage therapy</description>
        </group>
        <group group_id="B3">
          <title>Laser and Mld Combined</title>
          <description>therapist administered laser and mld
Low Level Laser Therapy with Manual Lymphatic Drainage: therapist will give both mld and laser treatment</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="15"/>
            <count group_id="B4" value="46"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.4" spread="11.3"/>
                    <measurement group_id="B2" value="67.5" spread="10.3"/>
                    <measurement group_id="B3" value="66.0" spread="10.2"/>
                    <measurement group_id="B4" value="66.6" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time from surgery to lymphedema diagnosis</title>
          <units>months</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.2" lower_limit="4" upper_limit="27"/>
                    <measurement group_id="B2" value="14.8" lower_limit="5" upper_limit="108"/>
                    <measurement group_id="B3" value="30.0" lower_limit="2" upper_limit="84"/>
                    <measurement group_id="B4" value="11.1" lower_limit="3" upper_limit="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of lymphedema prior to study enrollment</title>
          <units>months</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.0" lower_limit="6" upper_limit="58"/>
                    <measurement group_id="B2" value="18.9" lower_limit="5" upper_limit="73"/>
                    <measurement group_id="B3" value="25.2" lower_limit="6" upper_limit="142"/>
                    <measurement group_id="B4" value="25.4" lower_limit="6" upper_limit="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>LDex Change-</title>
        <description>Bioimpedance measured by units of LDex. As extracellular fluid accumulates (i.e. lymphedema develops) the LDex value increases.</description>
        <time_frame>Bioimpedance at baseline and end of treatment with the average number of treaments being 9 conducted over a median of up to 4 weeks.</time_frame>
        <population>LDex units.</population>
        <group_list>
          <group group_id="O1">
            <title>Laser Therapy Alone</title>
            <description>therapist administered laser treatment
laser: therapist administered laser</description>
          </group>
          <group group_id="O2">
            <title>Mld Alone</title>
            <description>therapist administered manual lymphatic drainage
manual lymphatic drainage: therapist administered massage therapy</description>
          </group>
          <group group_id="O3">
            <title>Laser and Mld Combined</title>
            <description>therapist administered laser and mld
Low Level Laser Therapy with Manual Lymphatic Drainage: therapist will give both mld and laser treatment</description>
          </group>
        </group_list>
        <measure>
          <title>LDex Change-</title>
          <description>Bioimpedance measured by units of LDex. As extracellular fluid accumulates (i.e. lymphedema develops) the LDex value increases.</description>
          <population>LDex units.</population>
          <units>LDex</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.0" lower_limit="17" upper_limit="35"/>
                    <measurement group_id="O2" value="17.8" lower_limit="3" upper_limit="38"/>
                    <measurement group_id="O3" value="22.2" lower_limit="11" upper_limit="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Symptoms</title>
        <description>Yes/no response to a symptom listed on the Lymphedema Symptom Intensity and Distress Scale-Arm (LSIDS-A) self-report form.</description>
        <time_frame>Self report on last day of treatment with average treatments being 9 conducted over a median of up to 4 weeks.</time_frame>
        <population>Total number of reported symptoms. Range of symptoms reported could be 0 to 36. Greater number of symptoms represents worse outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Laser Therapy Alone</title>
            <description>therapist administered laser treatment
laser: therapist administered laser</description>
          </group>
          <group group_id="O2">
            <title>Mld Alone</title>
            <description>therapist administered manual lymphatic drainage
manual lymphatic drainage: therapist administered massage therapy</description>
          </group>
          <group group_id="O3">
            <title>Laser and Mld Combined</title>
            <description>therapist administered laser and mld
Low Level Laser Therapy with Manual Lymphatic Drainage: therapist will give both mld and laser treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Symptoms</title>
          <description>Yes/no response to a symptom listed on the Lymphedema Symptom Intensity and Distress Scale-Arm (LSIDS-A) self-report form.</description>
          <population>Total number of reported symptoms. Range of symptoms reported could be 0 to 36. Greater number of symptoms represents worse outcome.</population>
          <units>symptoms</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="4" upper_limit="16"/>
                    <measurement group_id="O2" value="12.5" lower_limit="6" upper_limit="16"/>
                    <measurement group_id="O3" value="14" lower_limit="10" upper_limit="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life</title>
        <description>The Functional Assessment of Chronic Illness Therapy that measure quality of life -total score. Range of scores could be 0 to 148. Higher score represents higher quality of life.</description>
        <time_frame>Self-report on last day of treatment with average number of treatments being 9 conducted over a median of up to 4 weeks.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Laser Therapy Alone</title>
            <description>therapist administered laser treatment
laser: therapist administered laser</description>
          </group>
          <group group_id="O2">
            <title>Mld Alone</title>
            <description>therapist administered manual lymphatic drainage
manual lymphatic drainage: therapist administered massage therapy</description>
          </group>
          <group group_id="O3">
            <title>Laser and Mld Combined</title>
            <description>therapist administered laser and mld
Low Level Laser Therapy with Manual Lymphatic Drainage: therapist will give both mld and laser treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life</title>
          <description>The Functional Assessment of Chronic Illness Therapy that measure quality of life -total score. Range of scores could be 0 to 148. Higher score represents higher quality of life.</description>
          <units>total score</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="113.5" lower_limit="100" upper_limit="129"/>
                    <measurement group_id="O2" value="116.25" lower_limit="98" upper_limit="123"/>
                    <measurement group_id="O3" value="110" lower_limit="102" upper_limit="123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Whole Arm Volume Difference</title>
        <description>Whole arm measurement to determine volume.</description>
        <time_frame>Baseline and on last day of treatment with average number of treatments being 9 conducted over a median of up to 4 weeks.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Laser Therapy Alone</title>
            <description>therapist administered laser treatment
laser: therapist administered laser</description>
          </group>
          <group group_id="O2">
            <title>Mld Alone</title>
            <description>therapist administered manual lymphatic drainage (mld)
manual lymphatic drainage: therapist administered massage therapy</description>
          </group>
          <group group_id="O3">
            <title>Laser and Mld Combined</title>
            <description>therapist administered laser and mld
Low Level Laser Therapy with Manual Lymphatic Drainage: therapist will give both mld and laser treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Whole Arm Volume Difference</title>
          <description>Whole arm measurement to determine volume.</description>
          <units>Whole Arm Volume % Difference</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.0" lower_limit="3" upper_limit="23"/>
                    <measurement group_id="O2" value="6.8" lower_limit="0" upper_limit="17"/>
                    <measurement group_id="O3" value="13.4" lower_limit="2" upper_limit="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Participants were followed through the last treatment and there was an average of 9 treatments per group.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Laser Therapy Alone</title>
          <description>therapist administered laser treatment
laser: therapist administered laser
No adverse events during the study.</description>
        </group>
        <group group_id="E2">
          <title>Mld Alone</title>
          <description>therapist administered manual lymphatic drainage
manual lymphatic drainage: therapist administered massage therapy
No adverse events during the study.</description>
        </group>
        <group group_id="E3">
          <title>Laser and Mld Combined</title>
          <description>therapist administered laser and mld
Low Level Laser Therapy with Manual Lymphatic Drainage: therapist will give both mld and laser treatment
No adverse events during the study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sheila H, Ridner, PHD</name_or_title>
      <organization>Vanderbilt University School of Nursing</organization>
      <phone>615-322-0831</phone>
      <email>Sheila.Ridner@Vanderbilt.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

